Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Cancer Biomarkers Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024 -

Research and Markets
Posted on: 21 Dec 18

The "Cancer Biomarkers Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024" report has been added to's offering.

The report on the global cancer biomarkers market provides qualitative and quantitative analysis for the period from 2016 to 2024.

The report predicts the global cancer biomarkers market to grow with a CAGR of 10.5% over the forecast period from 2018-2024. The study on cancer biomarkers market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on cancer biomarkers market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cancer biomarkers market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cancer biomarkers market over the period of 2016 to 2024. Further, the Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Market Dynamics


  • Increasing occurrences of several types of cancers
  • Increasing advancements in biologics technologies


  • High capital investment
  • Safety and disposal considerations in specimen collection and storage


  • Increasing awareness among healthcare professionals
  • Rising demand for personalized medicine

Key Topics Covered

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Cancer Biomarkers Market Highlights

2.2. Cancer Biomarkers Market Projection

2.3. Cancer Biomarkers Market Regional Highlights

3. Global Cancer Biomarkers Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Biomolecule Type

3.4.2. Growth Matrix Analysis by Cancer Type

3.4.3. Growth Matrix Analysis by Application

3.4.4. Growth Matrix Analysis by End-Users

3.4.5. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Cancer Biomarkers Market

4. Cancer Biomarkers Market Macro Indicator Analysis

5. Global Cancer Biomarkers Market by Biomolecule Type

5.1. Genetic

5.2. Epigenetic

5.3. Metabolic

5.4. Proteomic

6. Global Cancer Biomarkers Market by Cancer Type

6.1. Breast Cancer

6.2. Lung Cancer

6.3. Prostate Cancer

6.4. Colorectal Cancer

6.5. Stomach Cancer

6.6. Skin Cancer

6.7. Ovarian Cancer

6.8. Blood Cancer

6.9. Others

7. Global Cancer Biomarkers Market by Application

7.1. Diagnostics

7.2. Prognostics

7.3. Risk Assessment

7.4. Drug Discovery and Development

7.5. Others

8. Global Cancer Biomarkers Market by End-Users

8.1. Hospitals

8.2. Speciality Centers

8.3. Academic and Cancer Research Centers

9. Global Cancer Biomarkers Market by Region 2018-2024

9.1. North America

9.2. Europe

9.3. Asia-Pacific

9.4. RoW

10. Company Profiles and Competitive Landscape

10.1. Competitive Landscape in the Global Cancer Biomarkers Market

10.2. Companies Profiles

10.2.1. F. Hoffmann-La Roche Ltd

10.2.2. Abbott Laboratories

10.2.3. GlaxoSmithKline plc

10.2.4. Novartis AG

10.2.5. Merck & Co., Inc

10.2.6. Becton, Dickinson and Company

10.2.7. Hologic, Inc.

10.2.8. Genomic Health, Inc

10.2.9. Agilent Technologies, Inc.

10.2.10. Illumina, Inc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 21/12/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.